About this trial
Coronary artery disease, caused by the furring up of the heart arteries by atherosclerosis, is a major cause of death in the UK. Despite existing therapies, adverse cardiovascular events remains high, especially in patients who have already had a heart attack, as some of these patients have aggressive atherosclerotic disease. If we could identify these vulnerable patients, then in wider clinical practice in the future we might be able to treat them better with new therapies that can otherwise be expensive or come with a risk of side-effects. Traditionally, the assessment of atherosclerotic disease and the identification of the plaques that will cause heart attacks is performed using invasive imaging - imaging taken by passing a wire into the arteries of the heart that has a camera on its tip. Invasive imaging, however, can be used only in patients with symptoms and has risks. Photon counting (PC) CT is a new CT system that has image quality comparable to invasive imaging and can be used in the community to examine individuals with stable angina symptoms. In this study we aim to compare how well PC-CT detects high-risk plaques compared with invasive imaging and in due course develop a platform that will expedite the analysis of CT images to allow its broad use in the clinical practice.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Able and willing to give informed consent
Between ages 18-79
Patients with a stable coronary syndrome that had recent PC-CTA showing at least one lesion requiring further evaluation with intravascular imaging or fractional flow reserve and is considered suitable for PCI under IVUS guidance
Disqualifiers
Unable to or unwilling to give informed consent
Age >80 years
Recent acute coronary syndrome within < 3 months
Renal failure (eGFR <60ml/min/1.73m²)
Trial population
Patients with a chronic coronary syndrome
Trial design
Cohort
Prospective
Treatments tested in this trial
observational study
Other interventionObservation study comparing Photon-counting CT with intravascular coronary imaging in patients with chronic coronary syndrome
Treatment groups
Trial outcomes
Primary outcomes
Compare the efficacy of PC-CTA and of conventional CTA in assessing the percent atheroma volume (PAV) using the output of the NIRS-IVUS analysis as the reference standard
Secondary outcomes
Identify the optimal reconstruction method of PC-CTA data for measuring the PAV in the studied segment using the NIRS-IVUS estimations as the reference standard.
Compare the accuracy of PC-CTA and conventional CTA in measuring flow patterns.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.